GPC
AGN.PRA

Guardian Point Capital’s Allergan plc AGN.PRA Stock Holding History

Guardian Point Capital’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,000
Closed -$6.67M – 18
2016
Q2 		$6.67M Buy
+8,000
New +$6.68M 5.41% 9

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Guardian Point Capital's AGN.PRA Position: Q3 2016 in Review

Guardian Point Capital sold out of Allergan plc (AGN.PRA) in Q3 2016, closing a stake of 8,000 shares — an estimated $6.67M sold.

Guardian Point Capital first reported a position in AGN.PRA in Q2 2016 and held it in 1 quarter. The position peaked at $6.67M in Q2 2016. 117 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2016.

  • Guardian Point Capital reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Guardian Point Capital sold 8,000 Allergan plc shares in Q3 2016, an estimated $6.67M.
  • Guardian Point Capital first reported a position in Allergan plc in Q2 2016 and held it in 1 quarter.
  • Guardian Point Capital's Allergan plc position peaked at $6.67M in Q2 2016.
  • 117 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Guardian Point Capital's 13F filing for Q3 2016, filed 14 Nov 2016.